Oxygen tension level and human viral infections

Virology

Volumn 444, Issue 1-2, 2013, Pages 31-36

  Morinet, Frédéric ^a,b   Casetti, Luana ^c   François, Jean Hugues ^c,d,e   Capron, Claude ^c,d,e   Pillet, Sylvie ^f,g  

^a SAINT LOUIS HOSPITAL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c INSTITUT COCHIN   (France)

^d HÔpital Ambroise Paré   (France)

^e LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^f UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^g UNIVERSITÉ JEAN MONNET   (France)

Author keywords

HIF 1 alpha inhibitor; Hypoxia; Hypoxia inducible factor 1 alpha; Oxygen tension level and viruses

Indexed keywords

ERLOTINIB; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1BETA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; NITRIC OXIDE; ONCOLYTIC VIRUS; PROTEIN INHIBITOR; REACTIVE OXYGEN METABOLITE; SORAFENIB;

DOWN REGULATION; DRUG EFFECT; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GLIOMA; HEPATITIS B; HEPATITIS C; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 8; KAPOSI SARCOMA; KIDNEY CARCINOMA; LIVER CELL CARCINOMA; LUNG NON SMALL CELL CANCER; NONHUMAN; OXYGEN SENSING; OXYGEN TENSION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; SHORT SURVEY; SIGNAL TRANSDUCTION; UPREGULATION; VIRUS GENE; VIRUS INFECTION; VIRUS REPLICATION;

HIF-1 ALPHA INHIBITOR; HYPOXIA; HYPOXIA INDUCIBLE FACTOR 1 ALPHA; OXYGEN TENSION LEVEL AND VIRUSES;

ANTIVIRAL AGENTS; DRUG THERAPY; DRUG THERAPY, COMBINATION; HUMANS; OXYGEN; VIRUS DISEASES;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84882889817     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2013.06.018     Document Type: Short Survey

References (74)

1. Bardos J.I., Ashcroft M. Negative and positive regulation of HIF-1: a complex network. Biochim. Biophys. Acta 2005, 1755(2):107-120.
2. Benders A.A., Tang W., Middeldorp J.M., Greijer A.E., Thorne L.B., Funkhouser W.K., Rathmell W.K., Gulley M.L. Epstein-Barr virus latent membrane protein 1 is not associated with vessel density nor with hypoxia inducible factor 1 alpha expression in nasopharyngeal carcinoma tissue. Head Neck Pathol. 2009, 3(4):276-282.
3. Berra E., Ginouves A., Pouyssegur J. The hypoxia-inducible-factor hydroxylases bring fresh air into hypoxia signalling. EMBO Rep. 2006, 7(1):41-45.
4. Cai Q.L.K., Verma S.C., Si H., Lin D., Robertson E.S. Kaposi's sarcoma-associated herpesvirus latent protein LANA interacts with HIF-1 alpha to upregulate RTA expression during hypoxia: latency control under low oxygen conditions. J. Virol. 2006, 80(16):7965-7975.
5. Cai Q.M.M., Si H., Robertson E.S. A potential alpha-helix motif in the amino terminus of LANA encoded by Kaposi's sarcoma-associated herpesvirus is critical for nuclear accumulation of HIF-1alpha in normoxia. J. Virol. 2007, 81(19):10413-10423.
6. Calfon M., Zeng H., Urano F., Till J.H., Hubbard S.R., Harding H.P., Clark S.G., Ron D. IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA. Nature 2002, 415(6867):92-96.
7. Carroll P.A.K.H., Yeung R.S., Lagunoff M. Latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells activates hypoxia-induced factors. J. Virol. 2006, 80(21):10802-10812.
8. Chen A.Y., Kleiboeker S., Qiu J. Productive parvovirus B19 infection of primary human erythroid progenitor cells at hypoxia is regulated by STAT5A and MEK signaling but not HIFalpha. PLoS Pathog. 2011, 7(6):e1002088.
9. Cho I.R., Koh S.S., Min H.J., Park E.H., Ratakorn S., Jhun B.H., Jeong S.H., Yoo Y.H., Youn H.D., Johnston R.N., Chung Y.H. Down-regulation of HIF-1alpha by oncolytic reovirus infection independently of VHL and p53. Cancer Gene Ther. 2010, 17(5):365-372.
10. Coppin C.K.C., Le L., Porzsolt F., Wilt T.J. Targeted therapy for advanced renal cell cancer (RCC): a Cochrane systematic review of published randomised trials. BJU Int. 2011, 108(10):1556-1563.
11. Dalton-Griffin L.W.S., Kellam P. X-box binding protein 1 contributes to induction of the Kaposi's sarcoma-associated herpesvirus lytic cycle under hypoxic conditions. J. Virol. 2009, 83(14):7202-7209.
12. Darekar S.G.K., Yurchenko M., Yenamandra S.P., Chachami G., Simos G., Klein G., Kashuba E. Epstein-Barr virus immortalization of human B-cells leads to stabilization of hypoxia-induced factor 1 alpha, congruent with the Warburg effect. PLoS One 2012, 7(7):e42072.
13. Davis D.A.R.A., Zoeteweij J.P., Aoki Y., Read-Connole E.L., Tosato G., Blauvelt A., Yarchoan R. Hypoxia induces lytic replication of Kaposi sarcoma-associated herpesvirus. Blood 2001, 97(10):3244-3250.
14. Deshmane S.L., Amini S., Sen S., Khalili K., Sawaya B.E. Regulation of the HIV-1 promoter by HIF-1alpha and Vpr proteins. Virol. J. 2011, 8:477.
15. Deshmane S.L., Mukerjee R., Fan S., Del Valle L., Michiels C., Sweet T., Rom I., Khalili K., Rappaport J., Amini S., Sawaya B.E. Activation of the oxidative stress pathway by HIV-1 Vpr leads to induction of hypoxia-inducible factor 1alpha expression. J. Biol. Chem. 2009, 284(17):11364-11373.
16. Ebbesen P., Toth F.D., Villadsen J.A., Norskov-Lauritsen N. In vitro interferon and virus production at in vivo physiologic oxygen tensions. In Vivo 1991, 5(4):355-358.
17. Ebbesen P., Zachar V. Oxygen tension and virus replication. Acta Virol. 1998, 42(6):417-421.
18. Eltzschig H.K., Carmeliet P. Hypoxia and inflammation. N. Engl. J. Med. 2011, 364(7):656-665.
19. Forner A., Llovet J., Bruix J. Hepatocellular carcinoma. Lancet 2012, 379(9822):1245-1555.
20. Fung J., Lai C.L., Yuen M.F. Hepatitis B and C virus-related carcinogenesis. Clin. Microbiol. Infect. 2009, 15(11):964-970.
21. Ganem D. KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine. J. Clin. Invest. 2010, 120(4):939-949.
22. Haeberle H.A., Durrstein C., Rosenberger P., Hosakote Y.M., Kuhlicke J., Kempf V.A., Garofalo R.P., Eltzschig H.K. Oxygen-independent stabilization of hypoxia inducible factor (HIF)-1 during RSV infection. PLoS One 2008, 3(10):e3352.
23. Han H.K., Han C.Y., Cheon E.P., Lee J., Kang K.W. Role of hypoxia-inducible factor-alpha in hepatitis-B-virus X protein-mediated MDR1 activation. Biochem. Biophys. Res. Commun. 2007, 357(2):567-573.
24. Haque M., Kousoulas K.G. The Kaposi's sarcoma-associated herpesvirus ORF34 protein binds to HIF-1α and causes its degradation via the proteasome pathway. J. Virol. 2013, 87(4):2164-2173.
25. Haque M.D.D., Wang V., Widmer I., Yarchoan R., Jun J.V. Kaposi's sarcoma- associated herpesvirus (human herpesvirus 8) contains hypoxia response elements: relevance to lytic induction by hypoxia. J. Virol. 2003, 77(12):6761-6768.
26. Hewitson K.S., McNeill L.A., Riordan M.V., Tian Y.M., Bullock A.N., Welford R.W., Elkins J.M., Oldham N.J., Bhattacharya S., Gleadle J.M., Ratcliffe P.J., Pugh C.W., Schofield C.J. Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family. J. Biol. Chem. 2002, 277(29):26351-26355.
27. Hirota K., Semenza G.L. Regulation of hypoxia-inducible factor 1 by prolyl and asparaginyl hydroxylases. Biochem. Biophys. Res. Commun. 2005, 338(1):610-616.
28. Hwang I.I., Watson I.R., Der S.D., Ohh M. Loss of VHL confers hypoxia-inducible factor (HIF)-dependent resistance to vesicular stomatitis virus: role of HIF in antiviral response. J. Virol. 2006, 80(21):10712-10723.
29. 2 sensing. Science 2001, 292(5516):464-468.
30. 2-regulated prolyl hydroxylation. Science 2001, 292(5516):468-472.
31. Jham B.C.M.T., Hu J., Chaisuparat R., Friedman E.R., Pandolfi P.P., Schneider A., Sodhi A., Montaner S. Amplification of the angiogenic signal through the activation of the TSC/mTOR/HIF axis by the KSHV vGPCR in Kaposi's sarcoma. PLoS One 2011, 6(4):e19103.
32. Kaelin W.G., Ratcliffe P.J. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol. Cell 2008, 30(4):393-402.
33. Kalter S.S., Tepperman J. Influenza Virus Proliferation in Hypoxic Mice. Science 1952, 115(2997):621-622.
34. Kar-Roy A., Korkaya H., Oberoi R., Lal S.K., Jameel S. The Hepatite E open reading frame 3 protein activates ERK through binding and inhibition of the MAPK phosphatase. J. Biol. Chem 2004, 279:28345-28357.
35. Kilani M.M., Mohammed K.A., Nasreen N., Tepper R.S., Antony V.B. RSV causes HIF-1alpha stabilization via NO release in primary bronchial epithelial cells. Inflammation 2004, 28(5):245-251.
36. Kondo S.S.S., Yoshizaki T., Wakisaka N., Furukawa M., Joab I., Jang K.L., Pagano J.S. EBV latent membrane protein 1 up-regulates hypoxia-inducible factor 1 alpha through Siah1-mediated down-regulation of prolyl hydroxylaes 1 and 3 in nasopharyngeal epithelial cells. Cancer Res. 2006, 66(20):9870-9877.
37. Lando D., Peet D.J., Whelan D.A., Gorman J.J., Whitelaw M.L. Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science 2002, 295(5556):858-861.
38. Loenarz C., Coleman M.L., Boleininger A., Schierwater B., Holland P.W., Ratcliffe P.J., Schofield C.J. The hypoxia-inducible transcription factor pathway regulates oxygen sensing in the simplest animal, Trichoplax adhaerens. EMBO Rep. 2011, 12(1):63-70.
39. Loisel-Meyer S.S.L., Craveiro M., Oburoglu L., Mongellaz C., Costa C., Martinez M., Cosset F.L., Battini J.L., Herzenberg L.A., Herzenberg L.A., Atkuri K.R., Sitbon M., Kinet S., Verhoeyen E., Taylor N. Glut1-mediated glucose transport regulates HIV infection. PNAS 2012, 109(7):2549-2554.
40. Lupberger J.Z.M., Xiao F., Thumann C., Fofana I., Zona L., Davis C., Mee C.J., Turek M., Gorke S., Royer C., Fischer B., Zahid M.N., Lavillette D., Fresquet J., Cosset F.L., Rothenberg S.M., Pietschmann T., Patel A.H., Pessaux P., Doffoël M., Raffelsberger W., Poch O., McKeating J.A., Brino L., Baumert T.F. EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy. Nat. Med. 2011, 17(5):589-595.
41. Magill T.P., Francis T. Studies with human influenza virus cultivated in artificial medium. J. Exp. Med. 1936, 63(6):803-811.
42. Majmundar A.J., Wong W.J., Simon M.C. Hypoxia-inducible factors and the response to hypoxic stress. Mol. Cell 2010, 40(2):294-309.
43. Maxwell P.H., Wiesener M.S., Chang G.W., Clifford S.C., Vaux E.C., Cockman M.E., Wykoff C.C., Pugh C.W., Maher E.R., Ratcliffe P.J. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999, 399(6733):271-275.
44. McFarlane S.N.M., Sutherland J.S., Preston C.M. Interaction of the human cytomegalovirus particle with the host cell induces hypoxia-inducible factor 1 alpha. Virology 2011, 414(1):83-90.
45. Mermis J.G.H., Xue B., Li F., Tawfik O., Buch S., Bartolome S., O'Brien-Ladner A., Dhillon N. Hypoxia-inducible factor-1 alpha/platelet derived growth factor axis in HIV-associated pulmonary vascular remodeling. Respir. Res. 2011, 12(103):1-14.
46. Moin S.M.C.V., Arya R., Jameel S. The hepatitis E virus ORF3 protein stabilizes HIF-1 alpha and enhances HIF-1-mediated transcriptional activity through p300/CBP. Cell. Microbiol. 2009, 11(9):1409-1421.
47. Moon E.J.J.C., Jeong J.W., Kim K.R., Yu D.Y., Murakami S., Kim C.W., Kim K.W. Hepatitis B virus X protein induces angiogenesis by stabilizing hypoxia-inducible factor-1 alpha. FASEB J. 2004, 18(2):382-384.
48. Nakamura M., Bodily J.M., Beglin M., Kyo S., Inoue M., Laimins L.A. Hypoxia-specific stabilization of HIF-1α by human papillomaviruses. Virology 2009, 387:442-448.
49. Nasimuzzaman M.W.G., Mikolon D., Stupack D.G., Siddiqui A. Hepatitis C virus stabilizes hypoxia-inducible factor 1 alpha and stimulates the synthesis of vascular endothelial growth factor. J. Virol. 2007, 81(19):10249-10257.
50. Peyssonnaux C., Datta V., Cramer T., Doedens A., Theodorakis E.A., Gallo R.L., Hurtado-Ziola N., Nizet V., Johnson R.S. HIF-1alpha expression regulates the bactericidal capacity of phagocytes. J. Clin. Invest. 2005, 115(7):1806-1815.
51. Pillet S., Le Guyader N., Hofer T., NguyenKhac F., Koken M., Aubin J.T., Fichelson S., Gassmann M., Morinet F. Hypoxia enhances human B19 erythrovirus gene expression in primary erythroid cells. Virology 2004, 327(1):1-7.
52. Piña-Oviedo S.K.K., Del Valle L. Hypoxia inducible factor-1 alpha activation of the JCV promoter: role in the pathogenesis of progressive multifocal leukoencephalopathy. Acta Neuropathol. 2009, 118(2):235-247.
53. Pipiya T., Sauthoff H., Huang Y.Q., Chang B., Cheng J., Heitner S., Chen S., Rom W.N., Hay J.G. Hypoxia reduces adenoviral replication in cancer cells by downregulation of viral protein expression. Gene Ther. 2005, 12(11):911-917.
54. Polonis V.R., Anderson G.R., Vahey M.T., Morrow P.J., Stoler D., Redfield R.R. Anoxia induces human immunodeficiency virus expression in infected T cell lines. J. Biol. Chem. 1991, 266(18):11421-11424.
55. Quintero M., Brennan P.A., Thomas G.J., Moncada S. Nitric oxide is a factor in the stabilization of hypoxia-inducible factor-1alpha in cancer: role of free radical formation. Cancer Res. 2006, 66(2):770-774.
56. Richard D.E., Berra E., Gothié E., Roux D., Pouysségur J. p42/p44 mitogen activated protein kinases phosphorylate inducible-hypoxia factor (HIF-1α) and enhance the transcriptional activity of HIF-1. J. Biol. Chem. 1999, 274(46):32631-32637.
57. Rommelaere J.G.K., Angelova A.L., Daeffler L., Dinsart C., Kiprianova I., Schlehofer J.R., Raykov Z. Oncolytic parvoviruses as cancer therapeutics. Cytokine Growth Factor Rev 2010, 21(2-3):185-195.
58. Russell S.J., Peng K.W., Bell J.C. Oncolytic virotherapy. Nat. Biotechnol. 2012, 10,30(7):658-670.
59. Semenza G.L. Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene 2010, 29(5):625-634.
60. Semenza G.L. Hypoxia-inducible factors in physiology and medicine. Cell 2012, 148(3):399-408.
61. Semenza G.L., Wang G.L. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol. Cell. Biol. 1992, 12(12):5447-5454.
62. Shin Y.C.J.C., Gack M.U., Lee H.R., Jung J.U. Kaposi's sarcoma-associated herpesvirus viral IFN regulatory factor 3 stabilizes hypoxia-inducible factor-1 alpha to induce vascular endothelial growth factor expression. Cancer Res. 2008, 68(6):1751-1759.
63. Sodhi A.M.S., Patel V., Zohar M., Bais C., Mesri E.A., Gutkind J.S. The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1 alpha. Cancer Res. 2000, 60(17):4873-4880.
64. Tomaskova J., Oveckova I., Labudova M., Lukacikova L., Laposova K., Kopacek J., Pastorekova S., Pastorek J. Hypoxia induces the gene expression and extracellular transmission of persistent lymphocytic choriomeningitis virus. J. Virol. 2011, 85(24):13069-13076.
65. Uldrick T.S.W.K., Kumar P., O'Mahony D., Bernstein W., Aleman K., Polizzotto M.N., Steinberg S.M., Pittaluga S., Marshall V., Whitby D., Little R.F., Yarchoan R. Phase II study of bevacizumab in patients with HIV-associated Kaposi's sarcoma receiving antiretroviral therapy. J. Clin. Oncol. 2012, 30(13):1476-1483.
66. Vassilaki N., Kalliampakou K.I., Kotta-Loizou I., Befani C., Liakos P., Simos G., Mentis A.F., Kalliaropoulos A., Doumba P.P., Smirlis D., Foka P., Bauhofer O., Poenisch M., Windisch M.P., Lee M.E., Koskinas J., Bartenschlager R., Mavromara P. Low oxygen tension enhances hepatitis C virus replication. J. Virol. 2013, on line.
67. Veeranna R.P.H.M., Davis D.A., Yang M., Yarchoan R. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen induction by hypoxia and hypoxia-inducible factors. J. Virol. 2012, 86(2):1097-1108.
68. Wakisaka N., Kondo S., Yoshizaki T., Murono S., Furukawa M., Pagano J.S. Epstein-Barr virus latent membrane protein 1 induces synthesis of hypoxia-inducible factor 1 alpha. Mol. Cell. Biol. 2004, 24(12):5223-5234.
69. Wang H.W., Trotter M.W., Lagos D., Bourboulia D., Henderson S., Mäkinen T., Elliman S., Flanagan A.M., Alitalo K., Boshoff C. Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma. Nat. Genet. 2004, 36(7):687-693.
70. Wouters B.G., Koritzinsky M. Hypoxia signalling through mTOR and the unfolded protein response in cancer. Nat. Rev. Cancer 2008, 8(11):851-864.
71. Ye F., Gao.S.J. A novel role of hydrogen peroxide in Kaposi sarcoma-associated herpesvirus reactivation. Cell Cycle 2011, 10(19):3237-3238.
72. Yoo Y.G.N.T., Seo H.W., Seong J.K., Park C.K., Shin Y.K., Lee M.O. Hepatitis B virus X protein induces the expression of MTA1 and HDAC1 which enhances hypoxia signaling in hepatocellular carcinoma cells. Oncogene 2008, 27(24):3405-3413.
73. Yoo Y.G.O.S., Park E.S., Cho H., Lee N., Park H., Kim D.K., Yu D.Y., Seong J.K., Lee M.O. Hepatitis B virus X protein enhances transcriptional activity of hypoxia-inducible factor-1 alpha through activation of mitogen-activated protein kinase pathway. J. Biol. Chem. 2003, 278(40):39076-39084.
74. Zhang H.Q.D., Tan Y.S., Lee K., Gao P., Ren Y.R., Rey S., Hammer H., Chang D., Pili R., Dang C.V., Liu J.O., Semenza G.L. Digoxin and other cardiac glycosides inhibit HIF alpha synthesis and block tumor growth. Proc. Nat. Acad. Sci. U.S.A. 2008, 105(50):19579-19586.